: Complete genome sequence of Yersinia pestis strain 91001, an isolate avirulent to humans. DNA Res 2004,11(3):179–197.PubMedCrossRef 45. Simonet M, Riot B, Fortineau N, Berche P: Invasin production by Yersinia pestis is abolished by insertion of an IS200-like element within the inv

gene. Infect Immun 1996,64(1):375–379.PubMed 46. Pallen MJ, Wren BW: Bacterial pathogenomics. Nature 2007,449(7164):835–842.PubMedCrossRef 47. Simons K, Ikonen E: Functional rafts in cell membranes. Nature 1997,387(6633):569–572.PubMedCrossRef 48. Hayward RD, Hume PJ, Humphreys D, Phillips N, Smith K, Koronakis V: Clustering transfers the translocated Escherichia coli receptor into lipid rafts to stimulate reversible activation of c-Fyn. Cell Microbiol 2009,11(3):433–441.PubMedCrossRef 49. Baorto DM, Gao Z, Malaviya R, Dustin ML, van der Merwe A, Lublin DM, Abraham SN: Survival Cisplatin order of FimH-expressing enterobacteria in macrophages relies on glycolipid traffic. Nature 1997,389(6651):636–639.PubMedCrossRef 50. Hayward RD, Cain RJ, McGhie EJ, Phillips N, Garner MJ, Koronakis V: Cholesterol binding by the bacterial type III translocon is essential for virulence effector delivery into mammalian cells. Mol Microbiol 2005,56(3):590–603.PubMedCrossRef 51. Eitel

J, Dersch P: The YadA protein EPZ-6438 of Yersinia pseudotuberculosis mediates high-efficiency uptake into human cells under environmental conditions in which invasin is repressed. Infect Immun 2002,70(9):4880–4891.PubMedCrossRef 52. Hudson KJ, Bouton AH: Yersinia pseudotuberculosis adhesins regulate tissue-specific colonization and immune cell localization in a mouse model of systemic infection.

Infect Immun 2006,74(11):6487–6490.PubMedCrossRef 53. El Tahir Y, Skurnik M: YadA, the multifaceted Yersinia adhesin. Int J Med Microbiol 2001,291(3):209–218.PubMedCrossRef 54. Mowlds P, Kavanagh K: Effect of pre-incubation temperature on susceptibility of Galleria mellonella larvae to infection by Candida albicans . Mycopathologia 2008,165(1):5–12.PubMedCrossRef Celecoxib Authors’ contributions All authors read and approved the manuscript and contributed to experimental design. PS and BW contributed to manuscript preparation.”
“Background The genus Chlamydia consists of multiple obligate intracellular bacterial species that infect both humans and animals. The C. trachomatis organisms infect human ocular (serovars A to C) and urogenital/colorectal (serovars D to K & L1 to L3) epithelial tissues, causing trachoma [1] and sexually transmitted diseases [2–4] respectively; The C. pneumoniae organisms invade human respiratory system, not only causing respiratory diseases but also exacerbating pathologies in cardiovascular system [5–7]; C. muridarum (formerly known as C. trachomatis mouse pneumonitis agent, designated as MoPn; ref: [8]), although causing no known diseases in humans, has been used as a model pathogen for studying chlamydial pathogenesis and immune responses; The C.